Most notably, constitutive activation of NF-κB has been identified in a variety of tumors including pancreatic cancer [135] and it is known to contribute to the aggressive phenotype [136] and chemoresistance [137]. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.